Brief: Egetis Therapeutics Board Director Mats Blom Acquires 200,000 Shares

Egetis Therapeutics AB (publ)

31/05/2023 14:07

May 31 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * MATS BLOM, BOARD DIRECTOR OF CO, HAS ACQUIRED 200,000
ADDITIONAL
SHARES IN CO ON MAY 31, 2023

Source text for Eikon:  ID:nMFN1c4Pvn 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))